Relative to modern biotechnology.

California Senate Resolution 88 (SR88) acknowledges California's pivotal role in the development of modern biotechnology, highlighting significant scientific advancements such as recombinant DNA and genetic engineering that began in the early 1970s. The resolution honors the state's contributions to medicine and scientific innovation. It was introduced by Senator Catherine Blakespear and co-authored by Senators Josh Becker, Anna Caballero, Jerry McNerney, Tom Umberg, Suzette Valladares, and Scott Wiener. The resolution was adopted unanimously by the Senate on April 9, 2026. ([legiscan.com](https://legiscan.com/CA/bill/SR88/2025?utm_source=openai))

Media coverage of SR88 has been positive, emphasizing California's leadership in biotechnology and its impact on global scientific progress. The resolution has been praised for recognizing the state's historical and ongoing contributions to medical and scientific advancements. Analysts highlight the bipartisan support for the resolution as a testament to the shared appreciation of biotechnology's importance in California's economy and healthcare system.

There has been minimal negative media coverage regarding SR88. Some critics argue that while the resolution acknowledges past achievements, it does not address current challenges facing the biotechnology sector in California, such as regulatory hurdles and competition from other states. However, these critiques have been limited and have not significantly impacted the overall reception of the resolution.

Source: LegiScan roll call vote data.